gp96 heat shock protein-peptide complex vaccine
Term · Oncology and biomedicine · MLC-T-ONC-003637
A vaccine made from a patient’s tumor cells that may help the body’s immune system kill cancer cells. This vaccine is used to treat kidney cancer, a type of brain cancer called glioma, and metastatic melanoma (a type of skin cancer that has spread). It is also being studied in the treatment of other types of cancer. Also called gp96 HSP-peptide complex, Oncophage, and vitespen.
| Identifier | MLC-T-ONC-003637 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | gp96 HSP-peptide complex; Oncophage; vitespen |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-003637",
"term": "gp96 heat shock protein-peptide complex vaccine",
"field": "Oncology and biomedicine",
"definition": "A vaccine made from a patient’s tumor cells that may help the body’s immune system kill cancer cells. This vaccine is used to treat kidney cancer, a type of brain cancer called glioma, and metastatic melanoma (a type of skin cancer that has spread). It is also being studied in the treatment of other types of cancer. Also called gp96 HSP-peptide complex, Oncophage, and vitespen.",
"synonyms": [
"gp96 HSP-peptide complex",
"Oncophage",
"vitespen"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/gp96-heat-shock-protein-peptide-complex-vaccine/"
}
Record 8,148 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.